Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human immunodeficiency virus

ABSTRACT: Comparison of HIV-1 and HIV-2 Mutagenesis by Illumina Sequencing

PROVIDER: PRJNA287455 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR2071410_1.fastq.gz	Fastqsanger.gz
	SRR2071410_2.fastq.gz	Fastqsanger.gz
	SRR2071420_1.fastq.gz	Fastqsanger.gz
	SRR2071420_2.fastq.gz	Fastqsanger.gz
	SRR2071411_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Schlafen 5 Suppresses Human Immunodeficiency Virus Type 1 Transcription by Commandeering Cellular Epigenetic Machinery

Project description:Schlafen-5 (SLFN5) is an interferon-induced protein of the Schlafen family which are involved in immune responses and oncogenesis. To date, little is known regarding its anti-HIV-1 function. Here, the authors report that overexpression of SLFN5 inhibits HIV-1 replication and reduces viral mRNA levels, whereas depletion of endogenous SLFN5 promotes HIV-1 replication. Moreover, they show that SLFN5 markedly decreases the transcriptional activity of HIV-1 long terminal repeat (LTR) via binding to two sequences in the U5-R region, which consequently represses the recruitment of RNA polymerase Ⅱ to the transcription initiation site. Mutagenesis studies show the importance of nuclear localization and the N-terminal 1-570 amino acids fragment in the inhibition of HIV-1. Further mechanistic studies demonstrate that SLFN5 interacts with components of the PRC2 complex, G9a and Histone H3, thereby promoting H3K27me2 and H3K27me3 modification leading to silencing HIV-1 transcription. In concert with this, they find that SLFN5 blocks the activation of latent HIV-1. Altogether, their findings demonstrate that SLFN5 is a transcriptional repressor of HIV-1 through epigenetic modulation and a potential determinant of HIV-1 latency.

2022-05-24 | GSE197700 | GEO

Human immunodeficiency virus 1

Project description:Broad neutralizing HIV antibodies

| PRJNA294363 | ENA

Human immunodeficiency virus 1

Project description:HIV LTR terminus sequence

| PRJDB9357 | ENA

Human immunodeficiency virus 1

Project description:HIV-1 quasispecies analysis

| PRJDB3502 | ENA

Human immunodeficiency virus 1

Project description:Polymorphisms of HIV-1 integrase

| PRJDB3501 | ENA

Human immunodeficiency virus 1

Project description:HIV-1 V3-loop 454 sequencing to define virus tropism

| PRJNA188778 | ENA

Human Immunodeficiency Virus

Project description:Single strand consensus sequencing reveals that HIV type but not subtype significantly impacts viral mutation frequencies and spectra

| PRJNA387132 | ENA

Human immunodeficiency virus 1

Project description:Full-length HIV-1 envelope sequences

| PRJNA320111 | ENA

Human immunodeficiency virus 1

Project description:HIV WGS and Population Diversity Analysis

| PRJNA196138 | ENA

Human immunodeficiency virus 1

Project description:HIV-1 tropism determination Using NGS

| PRJDB3249 | ENA